TELUS Health conference 2023: Exploring the value of real-world evidence
Industry experts share their insights into how real-world evidence (RWE) can enhance reimbursement decision-making for private drug plans.
Read article
Insurers
Get in depth knowledge of the group health benefits industry in Canada, and learn from our experts on how you can best design employee benefits plans, while ensuring plan costs remain sustainable.
-
-
TELUS Health Conference: Understanding the mental health of tomorrow’s leaders
Discover the profound impact of the pandemic on workplace mental health and learn why employers must address it. Here's how employers can help create healthier workplaces to inspire future leaders.
Read article
-
TELUS Health conference 2023: A deeper dive into drug utilization
Diabetes, asthma, depression and attention deficit hyperactivity disorder (ADHD)—these categories are driving utilization and spend in private drug plans. Here's what private payors need to know.
Read article
-
Pension Indices by TELUS Health: April 2023
The Pension Indices by TELUS Health, released monthly, condense the journey that pension plans have experienced during the year.
Read article
-
TELUS Health conference 2023: What you need to know about drug data trends
The key drivers of change in spending by private drug plans in 2022 can be boiled down to two words: biosimilars and diabetes.
Read article
-
TELUS Health Annual Conference 2023
Presentations from April 26 and May 3, 2023.
Read article
-
How early mental health diagnoses can improve employees’ wellbeing
Employers are leading the way in terms of mental healthcare. But mental health success stories are dependent on early diagnosis and there continues to be significant barriers to access.
Read article
-
Pension Indices by TELUS Health
A look at the journey that pension plans have experienced during the year.
Read article
-
A sneak peek at TELUS Health Annual Conference 2023
For the 19th consecutive year, TELUS Health is looking forward to welcoming a record number of participants at our upcoming virtual annual conference.
Read article
-
Everything that’s happening with biosimilars in Canada
The slow but steady adoption of biosimilars is big news. With provinces increasingly making the switch to biosimilar medications, the biosimilar wave has started across Canada.
Read article
-
What private plans can expect in 2023 from Canada’s drug pipeline
Developments in the diabetes category—the second largest category by eligible amount in 2022—will have the biggest impact on private plans this year.
Read article
-
Five tools every plan sponsor should consider to cap benefits costs
The future of private drug insurance can be friendly, as long as plan sponsors take action in mitigating ever-increasing drug costs through a variety of strategies.
Read article
-
Unlocking better healthcare: make a pharmacist your partner
Ontario pharmacists are now able to prescribe medications for minor ailments, which expands their scope of practice and could lead to better healthcare outcomes and reduce stress on our healhtcare.
Read article
-
Top 5 health benefits trends of 2023
COVID-19 pushed an industry that was slowly digitizing to move quickly to meet the rapidly evolving needs of its employers and plan members.
Read article
-
5 levers to slow the rise of pharmacy benefits costs
Drug costs are on the rise, but there are ways to combat this. Check out our five levers to slowing the growth of pharmacy benefits costs.
Read article
-
Mental health in the workplace - a prime focus for employers
Mental health indicators are in decline lately, a function of the recent economic downturn and three years of a global pandemic. Many employees are feeling isolated, anxious and unproductive.
Read article
-
What you need to know about drug data trends in 2022.
For the second year in a row, fewer claims were made for prescription drugs while the average eligible amounts per insured and per claim increased.
Read article
-
TELUS Health Annual Conference 2022
Presentations from May 10 & 17, 2022 events "Retrospective 2021: Data trends and national benchmarks" with Shawn O’Brien, Principal, Data Enablement, TELUS Health
Read article
-
Don’t miss it: The 2022 Drug Data Trends & National Benchmarks report.
Year two of the COVID-19 pandemic saw the continuation of lower rates of prescribing for high-volume drugs such as antibiotics.
Read article
-
What’s your plan to help employees manage chronic conditions?
Explore some of the impacts of limited diagnostic and treatment services for chronic conditions and how to help minimize costs and support improved outcomes.
Read article
-
Loading more...
